Reflections on the Implementation of Low-Dose Computed Tomography Screening in Individuals at High Risk of Lung Cancer in Spain
Arch Bronconeumol. 2017 Oct;53(10):568-573.
doi: 10.1016/j.arbres.2017.03.004.
Epub 2017 Apr 14.
[Article in
English,
Spanish]
Authors
Pilar Garrido
1
, Marcelo Sánchez
2
, José Belda Sanchis
3
, Nicolás Moreno Mata
4
, Ángel Artal
5
, Ángel Gayete
6
, José María Matilla González
7
, José Marcelo Galbis Caravajal
8
, Dolores Isla
9
, Luis Paz-Ares
10
, Luis M Seijo
11
Affiliations
- 1 Servicio de Oncología Médica, Hospital Ramón y Cajal, Madrid, España. Electronic address: pgarrido.hrc@salud.madrid.org.
- 2 Servicio de Radiodiagnóstico, Hospital Clínic, Barcelona, España.
- 3 Servicio Mancomunado de Cirugía Torácica, Hospitales Universitari Mútua Terrassa, Sant Pau i Santa Creu y Mar, Barcelona, España.
- 4 Servicio de Cirugía Torácica, Hospital Universitario Virgen del Rocío, Sevilla, España.
- 5 Servicio de Oncología Médica, Hospital Universitario Miguel Servet, Zaragoza, España.
- 6 Servicio de Radiodiagnóstico, Hospital del Mar, Barcelona, España.
- 7 Servicio de Cirugía Torácica, Hospital Clínico Universitario, Valladolid, España.
- 8 Servicio de Cirugía Torácica, Hospital Universitario de La Ribera, Valencia, España.
- 9 Servicio de Oncología Médica, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España.
- 10 Servicio de Oncología Médica, Hospital Universitario 12 de Octubre, Madrid, España.
- 11 Servicio de Neumología, Hospital Universitario Fundación Jiménez Díaz, Instituto de Investigación Sanitaria, CIBERES, Madrid, España.
Abstract
Lung cancer (LC) is a major public health issue. Despite recent advances in treatment, primary prevention and early diagnosis are key to reducing the incidence and mortality of this disease. A recent clinical trial demonstrated the efficacy of selective screening by low-dose computed tomography (LDCT) in reducing the risk of both lung cancer mortality and all-cause mortality in high-risk individuals. This article contains the reflections of an expert group on the use of LDCT for early diagnosis of LC in high-risk individuals, and how to evaluate its implementation in Spain. The expert group was set up by the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR), the Spanish Society of Thoracic Surgery (SECT), the Spanish Society of Radiology (SERAM) and the Spanish Society of Medical Oncology (SEOM).
Keywords:
Computed tomography; Cáncer de pulmón; Lung cancer; Radiografía; Radiography; Supervivencia; Survival; Tabaco; Tobacco; Tomografía Computarizada.
Copyright © 2017 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Aged
-
Aged, 80 and over
-
Cost-Benefit Analysis
-
Early Detection of Cancer
-
Female
-
Humans
-
Lung Neoplasms / diagnostic imaging*
-
Lung Neoplasms / epidemiology
-
Male
-
Mass Screening / economics
-
Mass Screening / methods*
-
Middle Aged
-
Practice Guidelines as Topic
-
Predictive Value of Tests
-
Quality-Adjusted Life Years
-
Risk
-
Sensitivity and Specificity
-
Solitary Pulmonary Nodule / diagnostic imaging
-
Spain / epidemiology
-
Tomography, X-Ray Computed / economics
-
Tomography, X-Ray Computed / methods*